Published in Mass Spectrom Rev on March 20, 2006
Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet (2011) 3.23
The transcription unit architecture of the Escherichia coli genome. Nat Biotechnol (2009) 2.85
Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics (2011) 2.44
Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol Syst Biol (2010) 2.41
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14
A statistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics (2009) 2.07
Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02
MASIC: a software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features. Comput Biol Chem (2008) 1.61
Global systems-level analysis of Hfq and SmpB deletion mutants in Salmonella: implications for virulence and global protein translation. PLoS One (2009) 1.58
Establishing the proteome of normal human cerebrospinal fluid. PLoS One (2010) 1.53
Comparative bacterial proteomics: analysis of the core genome concept. PLoS One (2008) 1.49
Mass spectrometry-based proteomics: existing capabilities and future directions. Chem Soc Rev (2012) 1.47
Systematic Survey of Serine Hydrolase Activity in Mycobacterium tuberculosis Defines Changes Associated with Persistence. Cell Chem Biol (2016) 1.47
Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry. Genome Res (2007) 1.46
Top-down proteomics reveals a unique protein S-thiolation switch in Salmonella Typhimurium in response to infection-like conditions. Proc Natl Acad Sci U S A (2013) 1.46
Discovery of novel secreted virulence factors from Salmonella enterica serovar Typhimurium by proteomic analysis of culture supernatants. Infect Immun (2010) 1.44
Normalization of peak intensities in bottom-up MS-based proteomics using singular value decomposition. Bioinformatics (2009) 1.40
An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies. J Proteome Res (2010) 1.37
Structural and operational complexity of the Geobacter sulfurreducens genome. Genome Res (2010) 1.37
Accurate mass measurements in proteomics. Chem Rev (2007) 1.36
Proteomic analysis of stationary phase in the marine bacterium "Candidatus Pelagibacter ubique". Appl Environ Microbiol (2008) 1.33
A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res (2009) 1.31
IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics (2009) 1.28
Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample. J Proteome Res (2009) 1.24
Dynamically multiplexed ion mobility time-of-flight mass spectrometry. Anal Chem (2008) 1.21
Global proteomic analysis of two tick-borne emerging zoonotic agents: anaplasma phagocytophilum and ehrlichia chaffeensis. Front Microbiol (2011) 1.18
Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One (2011) 1.18
Membrane stresses induced by overproduction of free fatty acids in Escherichia coli. Appl Environ Microbiol (2011) 1.18
Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. J Proteome Res (2007) 1.16
Probing the conformation of the ISWI ATPase domain with genetically encoded photoreactive crosslinkers and mass spectrometry. Mol Cell Proteomics (2011) 1.14
Improving protein identification sensitivity by combining MS and MS/MS information for shotgun proteomics using LTQ-Orbitrap high mass accuracy data. Anal Chem (2008) 1.13
Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. J Proteome Res (2008) 1.13
High-precision frequency measurements: indispensable tools at the core of the molecular-level analysis of complex systems. Anal Bioanal Chem (2007) 1.10
Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS One (2013) 1.09
Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. J Virol (2013) 1.08
Proteogenomic analysis of a thermophilic bacterial consortium adapted to deconstruct switchgrass. PLoS One (2013) 1.08
Automated gain control ion funnel trap for orthogonal time-of-flight mass spectrometry. Anal Chem (2008) 1.08
A statistical method for assessing peptide identification confidence in accurate mass and time tag proteomics. Anal Chem (2011) 1.08
Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. Hum Genomics Proteomics (2009) 1.07
Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice. Toxicol Sci (2010) 1.07
Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 1.07
Identification of widespread adenosine nucleotide binding in Mycobacterium tuberculosis. Chem Biol (2013) 1.06
Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics (2011) 1.06
The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med (2007) 1.06
Elimination of systematic mass measurement errors in liquid chromatography-mass spectrometry based proteomics using regression models and a priori partial knowledge of the sample content. Anal Chem (2007) 1.06
Linear discriminant analysis-based estimation of the false discovery rate for phosphopeptide identifications. J Proteome Res (2008) 1.06
Plasma proteome response to severe burn injury revealed by 18O-labeled "universal" reference-based quantitative proteomics. J Proteome Res (2010) 1.05
Genome-scale modeling of light-driven reductant partitioning and carbon fluxes in diazotrophic unicellular cyanobacterium Cyanothece sp. ATCC 51142. PLoS Comput Biol (2012) 1.05
Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. Circ Res (2011) 1.04
Characterization of the human pancreatic islet proteome by two-dimensional LC/MS/MS. J Proteome Res (2006) 1.03
Quantitative ESI-TOF analysis of macromolecular assembly kinetics. Anal Chem (2008) 1.02
A computational strategy to analyze label-free temporal bottom-up proteomics data. J Proteome Res (2008) 1.02
Improved LC-MS/MS spectral counting statistics by recovering low-scoring spectra matched to confidently identified peptide sequences. J Proteome Res (2010) 1.02
SOCR Motion Charts: An Efficient, Open-Source, Interactive and Dynamic Applet for Visualizing Longitudinal Multivariate Data. J Stat Educ (2010) 1.02
Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med (2012) 1.02
Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes. J Proteome Res (2008) 1.01
Proteomic profiling of a layered tissue reveals unique glycolytic specializations of photoreceptor cells. Mol Cell Proteomics (2010) 1.01
A hybrid approach to protein differential expression in mass spectrometry-based proteomics. Bioinformatics (2012) 1.01
Generation of a predicted protein database from EST data and application to iTRAQ analyses in grape (Vitis vinifera cv. Cabernet Sauvignon) berries at ripening initiation. BMC Genomics (2009) 1.00
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J Exp Med (2012) 0.98
Application of the accurate mass and time tag approach in studies of the human blood lipidome. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.98
A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers. Mol Cell Proteomics (2011) 0.97
Protein dynamics in iron-starved Mycobacterium tuberculosis revealed by turnover and abundance measurement using hybrid-linear ion trap-Fourier transform mass spectrometry. Anal Chem (2008) 0.96
DeltAMT: a statistical algorithm for fast detection of protein modifications from LC-MS/MS data. Mol Cell Proteomics (2011) 0.96
MultiAlign: a multiple LC-MS analysis tool for targeted omics analysis. BMC Bioinformatics (2013) 0.95
Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. J Proteome Res (2013) 0.94
Activity-based protein profiling reveals mitochondrial oxidative enzyme impairment and restoration in diet-induced obese mice. PLoS One (2012) 0.94
Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. J Proteome Res (2011) 0.93
The application of mass-spectrometry-based protein biomarker discovery to theragnostics. Br J Clin Pharmacol (2010) 0.91
Mass spectrometry reveals specific and global molecular transformations during viral infection. J Proteome Res (2006) 0.91
Systems analysis of multiple regulator perturbations allows discovery of virulence factors in Salmonella. BMC Syst Biol (2011) 0.90
Analysis of non-enzymatically glycated peptides: neutral-loss-triggered MS(3) versus multi-stage activation tandem mass spectrometry. Rapid Commun Mass Spectrom (2008) 0.90
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation. PLoS One (2013) 0.90
Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p. J Biol Chem (2012) 0.89
Mycobacterium tuberculosis Ser/Thr protein kinase B mediates an oxygen-dependent replication switch. PLoS Biol (2014) 0.89
Application of survival analysis methodology to the quantitative analysis of LC-MS proteomics data. Bioinformatics (2012) 0.88
Integrated post-experiment monoisotopic mass refinement: an integrated approach to accurately assign monoisotopic precursor masses to tandem mass spectrometric data. Anal Chem (2010) 0.88
The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics (2012) 0.88
Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry (2011) 0.88
Technologies and approaches to elucidate and model the virulence program of salmonella. Front Microbiol (2011) 0.88
Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition. J Proteome Res (2007) 0.88
Characterization of strategies for obtaining confident identifications in bottom-up proteomics measurements using hybrid FTMS instruments. Anal Chem (2008) 0.87
A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses. PLoS One (2013) 0.87
An assessment of false discovery rates and statistical significance in label-free quantitative proteomics with combined filters. BMC Bioinformatics (2009) 0.87
Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels. Mol Cell Proteomics (2012) 0.86
Multiplexed activity-based protein profiling of the human pathogen Aspergillus fumigatus reveals large functional changes upon exposure to human serum. J Biol Chem (2012) 0.86
A multi-omic systems approach to elucidating Yersinia virulence mechanisms. Mol Biosyst (2012) 0.86
Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice. Toxicol Sci (2013) 0.86
Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice. BMC Syst Biol (2013) 0.86
Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation. J Biol Chem (2014) 0.86
Image analysis tools and emerging algorithms for expression proteomics. Proteomics (2010) 0.86
Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Mol Cell Proteomics (2010) 0.86
Mutations in global regulators lead to metabolic selection during adaptation to complex environments. PLoS Genet (2014) 0.85
Global analysis of Salmonella alternative sigma factor E on protein translation. J Proteome Res (2015) 0.84
Uterine deletion of Trp53 compromises antioxidant responses in the mouse decidua. Endocrinology (2012) 0.84
Mapping protein abundance patterns in the brain using voxelation combined with liquid chromatography and mass spectrometry. Methods (2009) 0.84
Analysis of N-glycoproteins using genomic N-glycosite prediction. J Proteome Res (2013) 0.84
SILACtor: software to enable dynamic SILAC studies. Anal Chem (2011) 0.84
Characterizing the Escherichia coli O157:H7 proteome including protein associations with higher order assemblies. PLoS One (2011) 0.84
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom (1994) 45.51
Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis (1999) 45.01
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30
Mass spectrometry-based proteomics. Nature (2003) 28.94
Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 21.92
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A (2004) 13.14
Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol (1999) 12.42
Signaling through scaffold, anchoring, and adaptor proteins. Science (1997) 9.48
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol (2002) 8.37
Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science (1999) 8.01
Analytical properties of the nanoelectrospray ion source. Anal Chem (1996) 7.12
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol (2003) 6.86
Automated reduction and interpretation of high resolution electrospray mass spectra of large molecules. J Am Soc Mass Spectrom (2000) 5.44
The role of protein phosphorylation in neural and hormonal control of cellular activity. Nature (1982) 5.30
Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom Rev (1998) 4.66
Glycosylation and the immune system. Science (2001) 4.39
Polyphasic taxonomy of the genus Shewanella and description of Shewanella oneidensis sp. nov. Int J Syst Bacteriol (1999) 4.30
An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics (2002) 4.10
Mass spectrometry in proteomics. Chem Rev (2001) 4.00
Determination of monoisotopic masses and ion populations for large biomolecules from resolved isotopic distributions. J Am Soc Mass Spectrom (1995) 3.92
Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem (2001) 3.78
Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci U S A (2002) 3.70
Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci U S A (2002) 3.15
Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol (2001) 3.14
Top down characterization of larger proteins (45 kDa) by electron capture dissociation mass spectrometry. J Am Chem Soc (2002) 2.72
Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Anal Biochem (1986) 2.55
Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50
Packed capillary reversed-phase liquid chromatography with high-performance electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics. Anal Chem (2001) 2.39
Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem (2002) 2.27
Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics (2004) 2.25
Statistical and computational methods for comparative proteomic profiling using liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics (2005) 2.24
Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res (2005) 2.22
Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and 15N-metabolic labeling. Anal Chem (2001) 2.06
Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal Chem (2004) 2.00
Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analyses. Anal Chem (2003) 2.00
High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal Chem (2004) 1.99
Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94
Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotations. Proc Natl Acad Sci U S A (2005) 1.93
Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom Rev (2005) 1.91
Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res (2003) 1.90
Ultrasensitive and quantitative analyses from combined separations-mass spectrometry for the characterization of proteomes. Acc Chem Res (2004) 1.88
High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal Chem (2002) 1.88
Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI? J Am Soc Mass Spectrom (2003) 1.86
Attomole protein characterization by capillary electrophoresis-mass spectrometry. Science (1996) 1.82
Proteomic analyses using an accurate mass and time tag strategy. Biotechniques (2004) 1.80
PRISM: a data management system for high-throughput proteomics. Proteomics (2006) 1.80
A tool to visualize and evaluate data obtained by liquid chromatography-electrospray ionization-mass spectrometry. Anal Chem (2004) 1.74
Direct mass spectrometric analysis of intact proteins of the yeast large ribosomal subunit using capillary LC/FTICR. Proc Natl Acad Sci U S A (2002) 1.72
18O labeling: a tool for proteomics. Rapid Commun Mass Spectrom (2001) 1.68
An automated high performance capillary liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometer for high-throughput proteomics. J Am Soc Mass Spectrom (2004) 1.68
Ultrasensitive proteomics using high-efficiency on-line micro-SPE-nanoLC-nanoESI MS and MS/MS. Anal Chem (2004) 1.66
The emerging significance of O-GlcNAc in cellular regulation. Chem Rev (2002) 1.65
Processing complex mixtures of intact proteins for direct analysis by mass spectrometry. Anal Chem (2002) 1.63
Dissection of proteolytic 18O labeling: endoprotease-catalyzed 16O-to-18O exchange of truncated peptide substrates. J Proteome Res (2003) 1.62
Proteome analyses using accurate mass and elution time peptide tags with capillary LC time-of-flight mass spectrometry. J Am Soc Mass Spectrom (2003) 1.59
Application of peptide LC retention time information in a discriminant function for peptide identification by tandem mass spectrometry. J Proteome Res (2004) 1.56
Mass spectrometric analysis of protein mixtures at low levels using cleavable 13C-isotope-coded affinity tag and multidimensional chromatography. Mol Cell Proteomics (2003) 1.53
Phosphoprotein isotope-coded affinity tag approach for isolating and quantitating phosphopeptides in proteome-wide analyses. Anal Chem (2001) 1.53
Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nat Biotechnol (2002) 1.53
Chromatographic alignment by warping and dynamic programming as a pre-processing tool for PARAFAC modelling of liquid chromatography-mass spectrometry data. J Chromatogr A (2002) 1.48
Automated gain control and internal calibration with external ion accumulation capillary liquid chromatography-electrospray ionization Fourier transform ion cyclotron resonance. Anal Chem (2003) 1.45
High-throughput proteomics using high-efficiency multiple-capillary liquid chromatography with on-line high-performance ESI FTICR mass spectrometry. Anal Chem (2001) 1.45
High-efficiency on-line solid-phase extraction coupling to 15-150-microm-i.d. column liquid chromatography for proteomic analysis. Anal Chem (2003) 1.44
Proteome analysis by mass spectrometry. Annu Rev Biophys Biomol Struct (2003) 1.44
Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers. J Am Soc Mass Spectrom (2003) 1.44
Phosphoprotein isotope-coded solid-phase tag approach for enrichment and quantitative analysis of phosphopeptides from complex mixtures. Anal Chem (2003) 1.39
Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr Opin Biotechnol (2003) 1.35
Physiologic determinants of radiation resistance in Deinococcus radiodurans. Appl Environ Microbiol (2000) 1.33
Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: the human mammary epithelial cell proteome. Proteomics (2005) 1.33
Perspectives for mass spectrometry and functional proteomics. Mass Spectrom Rev (2001) 1.33
ESI-FTICR mass spectrometry employing data-dependent external ion selection and accumulation. J Am Soc Mass Spectrom (2002) 1.31
Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol (2005) 1.29
Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents: the yeast salinity stress response. Mol Cell Proteomics (2003) 1.29
Targeted comparative proteomics by liquid chromatography-tandem Fourier ion cyclotron resonance mass spectrometry. Anal Chem (2005) 1.28
The utility of accurate mass and LC elution time information in the analysis of complex proteomes. J Am Soc Mass Spectrom (2005) 1.27
Multidimensional proteome analysis of human mammary epithelial cells. J Proteome Res (2004) 1.24
Stable isotope-coded proteomic mass spectrometry. Curr Opin Biotechnol (2003) 1.21
Zeptomole-sensitivity electrospray ionization--Fourier transform ion cyclotron resonance mass spectrometry of proteins. Anal Chem (2000) 1.19
High-throughput proteomics using Fourier transform ion cyclotron resonance mass spectrometry. Expert Rev Proteomics (2004) 1.18
Independent control of ion transmission in a jet disrupter dual-channel ion funnel electrospray ionization MS interface. Anal Chem (2002) 1.18
Initial implementation of an electrodynamic ion funnel with Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom (2000) 1.14
Identification of tryptic peptides from large databases using multiplexed tandem mass spectrometry: simulations and experimental results. Proteomics (2003) 1.12
Minimizing resolution of isotopically coded peptides in comparative proteomics. J Proteome Res (2003) 1.11
High-throughput peptide identification from protein digests using data-dependent multiplexed tandem FTICR mass spectrometry coupled with capillary liquid chromatography. Anal Chem (2001) 1.11
Multipole storage assisted dissociation, a novel in-source dissociation technique for electrospray ionization generated ions. Rapid Commun Mass Spectrom (1998) 1.06
Radial stratification of ions as a function of mass to charge ratio in collisional cooling radio frequency multipoles used as ion guides or ion traps. Rapid Commun Mass Spectrom (2000) 1.05
Temperature selectivity effects in reversed-phase liquid chromatography due to conformation differences between helical and non-helical peptides. J Chromatogr A (2003) 1.04
FTICR mass spectrometry for qualitative and quantitative bioanalyses. Curr Opin Biotechnol (2004) 1.04
Chemical strategies for functional proteomics. Mol Cell Proteomics (2002) 1.03
Design and performance of an ESI interface for selective external ion accumulation coupled to a Fourier transform ion cyclotron mass spectrometer. Anal Chem (2001) 1.02
High-mass-measurement accuracy and 100% sequence coverage of enzymatically digested bovine serum albumin from an ESI-FTICR mass spectrum. Anal Chem (1999) 1.01
Analysis of the Shewanella oneidensis proteome by two-dimensional gel electrophoresis under nondenaturing conditions. Proteomics (2003) 0.99
Evaluation of the acid-cleavable isotope-coded affinity tag reagents: application to camptothecin-treated cortical neurons. J Proteome Res (2004) 0.97
High-mass accuracy of product ions produced by SORI-CID using a dual electrospray ionization source coupled with FTICR mass spectrometry. Anal Chem (2001) 0.97
Quantitative proteomics using mass spectrometry. Curr Opin Chem Biol (2003) 0.96
Initial implementation of external accumulation liquid chromatography/electrospray ionization Fourier transform ion cyclotron resonance with automated gain control. Rapid Commun Mass Spectrom (2003) 0.95
Global whole-cell FTICR mass spectrometric proteomics analysis of the heat shock response in the radioresistant bacterium Deinococcus radiodurans. J Proteome Res (2005) 0.95
Temperature as a variable in reversed-phase high-performance liquid chromatographic separations of peptide and protein samples. I. Optimizing the separation of a growth hormone tryptic digest. J Chromatogr A (1994) 0.93
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res (2005) 4.13
Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics (2002) 3.57
DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics (2008) 3.51
Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet (2011) 3.23
How much will Herceptin really cost? BMJ (2006) 3.23
Chemically etched open tubular and monolithic emitters for nanoelectrospray ionization mass spectrometry. Anal Chem (2006) 3.22
VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics (2007) 3.15
Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci U S A (2002) 3.15
Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J Proteome Res (2006) 3.10
High-sensitivity ion mobility spectrometry/mass spectrometry using electrodynamic ion funnel interfaces. Anal Chem (2005) 2.99
An IMS-IMS analogue of MS-MS. Anal Chem (2006) 2.68
Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res (2007) 2.67
Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data. BMC Bioinformatics (2009) 2.65
Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48
Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics (2011) 2.44
Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol Syst Biol (2010) 2.41
Binding MOAD (Mother Of All Databases). Proteins (2005) 2.40
DeconMSn: a software tool for accurate parent ion monoisotopic mass determination for tandem mass spectra. Bioinformatics (2008) 2.38
Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem (2007) 2.38
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res (2005) 2.35
Integrative analysis of the mitochondrial proteome in yeast. PLoS Biol (2004) 2.31
Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator. J Am Chem Soc (2002) 2.29
Statistical characterization of the charge state and residue dependence of low-energy CID peptide dissociation patterns. Anal Chem (2005) 2.29
High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25
High-resolution field asymmetric waveform ion mobility spectrometry using new planar geometry analyzers. Anal Chem (2006) 2.19
Toward plasma proteome profiling with ion mobility-mass spectrometry. J Proteome Res (2006) 2.18
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14
Transport functions dominate the SAR11 metaproteome at low-nutrient extremes in the Sargasso Sea. ISME J (2008) 2.11
Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics (2006) 2.11
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08
A statistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics (2009) 2.07
Development and evaluation of a micro- and nanoscale proteomic sample preparation method. J Proteome Res (2005) 2.06
The genome of Cyanothece 51142, a unicellular diazotrophic cyanobacterium important in the marine nitrogen cycle. Proc Natl Acad Sci U S A (2008) 2.05
Ionization and transmission efficiency in an electrospray ionization-mass spectrometry interface. J Am Soc Mass Spectrom (2007) 2.03
Fundamentals of traveling wave ion mobility spectrometry. Anal Chem (2008) 2.02
Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02
Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analyses. Anal Chem (2003) 2.00
Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal Chem (2004) 2.00
High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal Chem (2004) 1.99
Binding MOAD, a high-quality protein-ligand database. Nucleic Acids Res (2007) 1.99
Clustering millions of tandem mass spectra. J Proteome Res (2007) 1.98
Head-to-head comparison of serum fractionation techniques. J Proteome Res (2007) 1.98
Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res (2005) 1.96
Spectral archives: extending spectral libraries to analyze both identified and unidentified spectra. Nat Methods (2011) 1.95
Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94
High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics (2004) 1.94
Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotations. Proc Natl Acad Sci U S A (2005) 1.93
Ion mobility spectrometry-mass spectrometry performance using electrodynamic ion funnels and elevated drift gas pressures. J Am Soc Mass Spectrom (2007) 1.93
Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment. J Proteome Res (2006) 1.93
Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom Rev (2005) 1.91
Ion funnel trap interface for orthogonal time-of-flight mass spectrometry. Anal Chem (2007) 1.88
High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal Chem (2002) 1.88
Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. Anal Chem (2005) 1.87
Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis (2007) 1.84
Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. Anal Chem (2006) 1.83
Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions. Mol Cell Proteomics (2006) 1.82
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology (2012) 1.82
Improving mass spectrometer sensitivity using a high-pressure electrodynamic ion funnel interface. J Am Soc Mass Spectrom (2006) 1.80
Proteomic analyses using an accurate mass and time tag strategy. Biotechniques (2004) 1.80
PRISM: a data management system for high-throughput proteomics. Proteomics (2006) 1.80
Does trypsin cut before proline? J Proteome Res (2007) 1.79
Enhanced ion utilization efficiency using an electrodynamic ion funnel trap as an injection mechanism for ion mobility spectrometry. Anal Chem (2008) 1.79
Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. Cell Rep (2013) 1.75
Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci U S A (2012) 1.75
Direct mass spectrometric analysis of intact proteins of the yeast large ribosomal subunit using capillary LC/FTICR. Proc Natl Acad Sci U S A (2002) 1.72
Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomes. Genome Res (2008) 1.68
An automated high performance capillary liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometer for high-throughput proteomics. J Am Soc Mass Spectrom (2004) 1.68
Home-based medication review in older people: is it cost effective? Pharmacoeconomics (2007) 1.67
Ultrasensitive proteomics using high-efficiency on-line micro-SPE-nanoLC-nanoESI MS and MS/MS. Anal Chem (2004) 1.66
Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2004) 1.66
Two-dimensional gas-phase separations coupled to mass spectrometry for analysis of complex mixtures. Anal Chem (2005) 1.65
Disclosure of genetic tests for health insurance: is it ethical not to? Lancet (2004) 1.65